Comparative Study
Biomarkers and IL-2R in lung cancer
Affiliations
- PMID: 1962891
Item in Clipboard
Comparative Study
Biomarkers and IL-2R in lung cancer
Recenti Prog Med.
1990 Nov.
Abstract
A study of TPA, CEA and IL-2R serum levels was conducted in patients untreated with various histological types of bronchial carcinoma. A total of 43 subjects were evaluated. We have observed a significant correlation between serum levels and stage of the disease for both CEA and TPA markers, whereas for IL-2R an increase was shown for the all patients not correlated with stage.
Similar articles
-
Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.Ann Thorac Surg. 2004 Sep;78(3):1004-9; discussion 1009-10. doi: 10.1016/j.athoracsur.2004.03.019. Ann Thorac Surg. 2004. PMID: 15337038
-
Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.Rocz Akad Med Bialymst. 2004;49:246-51. Rocz Akad Med Bialymst. 2004. PMID: 15631351
-
Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.Anticancer Res. 1999 Jul-Aug;19(4C):3613-8. Anticancer Res. 1999. PMID: 10629660
-
[Update regarding the role of biomarkers in early diagnosis of non-small cell bronchopulmonary cancer].Pneumologia. 2011 Jan-Mar;60(1):7, 9-13. Pneumologia. 2011. PMID: 21548194 Review. Romanian.
-
[Biological markers in lung cancer].Pneumonol Alergol Pol. 1991;59(5-6):253-9. Pneumonol Alergol Pol. 1991. PMID: 1668877 Review. Polish. No abstract available.
Cited by
-
Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib.J Cancer Res Clin Oncol. 2006 Nov;132(11):719-25. doi: 10.1007/s00432-006-0120-x. Epub 2006 Jul 12. J Cancer Res Clin Oncol. 2006. PMID: 16835747 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical